JG
MYGN icon

Jain Global’s Myriad Genetics MYGN Stock Holding History

Jain Global’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Buy
228,559
+199,844
+696% +$907K 0.01% 893
2026
Q1 		$129K Sell
28,715
-160,243
-85% -$835K ﹤0.01% 1113
2025
Q4 		$1.16M Buy
188,958
+111,484
+144% +$808K 0.01% 688
2025
Q3 		$560K Sell
77,474
-15,680
-17% -$93.1K ﹤0.01% 723
2025
Q2 		$495K Buy
93,154
+63,995
+219% +$378K ﹤0.01% 791
2025
Q1 		$259K Buy
+29,159
New +$350K ﹤0.01% 733

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jain Global's MYGN Position: Q2 2026 in Review

Jain Global increased its Myriad Genetics (MYGN) stake by 696% in Q2 2026, buying an estimated $907K and bringing the position to 228,559 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #893.

Jain Global first reported a position in MYGN in Q1 2025 and has held it in 6 quarters since. 197 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Jain Global held 228,559 shares of Myriad Genetics worth $1.31M as of Q2 2026.
  • Jain Global bought 199,844 Myriad Genetics shares in Q2 2026, an estimated $907K.
  • Myriad Genetics made up 0.01% of Jain Global's portfolio in Q2 2026, its #893 holding.
  • Jain Global first reported a position in Myriad Genetics in Q1 2025 and has held it in 6 quarters since.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.